BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16452487)

  • 1. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
    Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
    J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.
    Gewurz BE; Gaudet R; Tortorella D; Wang EW; Ploegh HL; Wiley DC
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6794-9. PubMed ID: 11391001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.
    Gewurz BE; Wang EW; Tortorella D; Schust DJ; Ploegh HL
    J Virol; 2001 Jun; 75(11):5197-204. PubMed ID: 11333901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules.
    Furman MH; Ploegh HL; Tortorella D
    J Biol Chem; 2002 Feb; 277(5):3258-67. PubMed ID: 11717308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.
    Williams M; Roeth JF; Kasper MR; Fleis RI; Przybycin CG; Collins KL
    J Virol; 2002 Dec; 76(23):12173-84. PubMed ID: 12414957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules.
    Chapman DC; Stocki P; Williams DB
    PLoS One; 2015; 10(12):e0145458. PubMed ID: 26691022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products.
    Story CM; Furman MH; Ploegh HL
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8516-21. PubMed ID: 10411907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
    Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
    Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules.
    Oresic K; Noriega V; Andrews L; Tortorella D
    J Biol Chem; 2006 Jul; 281(28):19395-406. PubMed ID: 16687410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased efficiency of folding and peptide loading of mutant MHC class I molecules.
    Beissbarth T; Sun J; Kavathas PB; Ortmann B
    Eur J Immunol; 2000 Apr; 30(4):1203-13. PubMed ID: 10760810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol.
    Kikkert M; Hassink G; Barel M; Hirsch C; van der Wal FJ; Wiertz E
    Biochem J; 2001 Sep; 358(Pt 2):369-77. PubMed ID: 11513735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.
    Bouvier M; Wiley DC
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4583-8. PubMed ID: 8643447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.